ERBB2 and triple-negative breast carcinoma: Besides, RHBDD1 upregulation is associated with poor prognosis in ER positive breast cancer, ER and PR positive breast cancer, HER2 positive breast cancer, PR positive breast cancer and triple negative breast cancer.